The world’s third most common cancer, colorectal cancer is responsible for an estimated 694,000 annual deaths worldwide; hence the disease is a hugely significant public health concern . The few last decades have brought great improvements in survival across all stages of the disease. Many factors contributes to this advancement; earlier diagnosis, better pre-operative staging, neoadjuvant radiochemotherapy, refined surgical methods , introduction of pre- and post-operative multidisciplinary team conferences and adjuvant chemotherapy.
To mark Colorectal Cancer Awareness month this March we are highlighting our top colorectal cancer content to provide you with the latest updates and challenges from the field.
In this piece, discover the key areas where major advancements in colorectal cancer have been made. Highlights include robotic surgery, immunotherapy and next-generation sequencing.
This article highlights important aspects of colorectal cancer management now and in the future, including new modalities such as robotics and organ preserving through wait-and-watch which will give colorectal surgeons even more treatment options.
In this interview Roshaine Wijayatunga (Senior Editor: Oncology) speaks with David Jayne about colorectal surgery in regards to the development, application and evaluation of new surgical technologies.
- Promising interim results from 680-subject colorectal cancer clinical trial
- MicroRNAs as a tool to aid stratification of colorectal cancer patients and to guide therapy
- ASCO17: Global study sets risk-based standard for chemotherapy for colon cancer
 http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspx (Accessed 28th February 2018)